17.08.2013 Views

Strategy For Limiting Risks Human Health Draft of ... - ECHA - Europa

Strategy For Limiting Risks Human Health Draft of ... - ECHA - Europa

Strategy For Limiting Risks Human Health Draft of ... - ECHA - Europa

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Repeated dose toxicity<br />

Local effects<br />

Inhalation exposure<br />

<strong>For</strong> prolonged inhalation exposure <strong>of</strong> workers to cryolite, data on possible health effects are<br />

available from different sources such as mining and processing <strong>of</strong> natural cryolite, production<br />

<strong>of</strong> syntethic cryolite and manufacturing <strong>of</strong> aluminium. There has been no indication for<br />

cryolite specific chronic respiratory effects in humans although specific examinations have<br />

been made (x-ray photography, pulmonary function tests, questionaires concerning incidences<br />

<strong>of</strong> acute pulmonary symptoms). Exposure in some cases has been rather high and longlasting,<br />

causing severe skeletal fluorosis.<br />

In a well-conducted 90-day inhalation study rats were exposed snout-only to particulate<br />

aerosols <strong>of</strong> cryolite in the concentration <strong>of</strong> 0, 0.21, 1.04, and 4.6 mg/m 3 . Alveolitis with<br />

interstitial thickening <strong>of</strong> alveolar duct walls and increased collagen in alveolar ducts occurred<br />

in the high dose group. At the intermediate dose <strong>of</strong> Cryolite, a proportion <strong>of</strong> rats had<br />

interstitial thickening <strong>of</strong> the alveolar duct walls. These effects might indicate <strong>of</strong> the start <strong>of</strong> a<br />

fibrotic process in the lung. At the low dose (0.21 mg/m 3 ) no effect was observed.<br />

<strong>For</strong> the risk assessment this NOAEC <strong>of</strong> 0.21 mg/m 3 is used as starting point concerning<br />

effects <strong>of</strong> cryolite after repeated inhalation.<br />

<strong>For</strong> the identification <strong>of</strong> the reference MOS the following aspects are taken into account: The<br />

human data give no indication for cryolite specific chronic respiratory effects. Therefore, the<br />

NOAEC gives a very precautious value for the evaluation <strong>of</strong> this endpoint. On that<br />

background it does not seem indicated to apply any additional assessment factors like inter- or<br />

intraspecies extrapolation or duration adjustment. On the other hand the NOAEC, based on a<br />

90-day study, might make a duration factor <strong>of</strong> about 2 necessary, because a progression <strong>of</strong><br />

effects in the lungs (thickening <strong>of</strong> alveolar ducts and increased collagen) cannot excluded. In<br />

summary for the reference MOS a value <strong>of</strong> about 2 is proposed; the critical exposure level<br />

calculates then to 0.1 mg/m 3 (0.2 mg/m 3 / 2).<br />

Table 2.2 shows, that all scenarios exceed the critical exposure level thus giving reason for<br />

concern.<br />

17<br />

Conclusion: iii

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!